tiprankstipranks
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
AMLX
Amylyx Pharmaceuticals Inc
RESEARCH TOOLSreports

Amylyx Pharmaceuticals Inc (AMLX) Stock News & Sentiment

657 Followers
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
Premium
Ratings
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
6d ago
AMLX
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
Premium
Company Announcements
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
21d ago
8K
AMLX
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
Premium
Ratings
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
29d ago
AMLX
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
Premium
Company Announcements
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
1M ago
AMLX
Amylyx Pharmaceuticals: Solid Balance Sheet, Advancing Pipeline, and Attractive Risk‑Reward Support Buy Rating
Premium
Ratings
Amylyx Pharmaceuticals: Solid Balance Sheet, Advancing Pipeline, and Attractive Risk‑Reward Support Buy Rating
1M ago
AMLX
Is AMLX a Buy, Before Earnings?
Premium
Pre-Earnings
Is AMLX a Buy, Before Earnings?
1M ago
AMLX
Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside
Premium
Ratings
Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside
3M ago
AMLX
More AMLX News >

AMLX News on the Web

Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
TipRanks News
Bullish
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Repligen (RGEN), Amylyx Pharmaceuticals Inc (AMLX)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Amylyx Highlights Pipeline Progress in Updated Corporate Presentation
TipRanks News
Neutral
Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide
TipRanks News
Bullish
LifeSci Capital Sticks to Its Buy Rating for Amylyx Pharmaceuticals Inc (AMLX)
TipRanks News
Bullish
Guggenheim Reaffirms Their Buy Rating on Amylyx Pharmaceuticals Inc (AMLX)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
AMLX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AMLX’s Media Buzz Sentiment?
1 articles about AMLX were published this week. In an average week, 2.25 articles are published.
    What is AMLX’s weekly average amount of articles?
    In an average week, 2.25 articles about AMLX are published.
      What is AMLX’s News Sentiment?
      100% of articles about AMLX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        STAAStaar Surgical
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week